| |
| |
|
| Insider
Information: |
Barlow David S |
| Relationship: |
10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,361,377 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,361,377 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Molecular Insight Pharmaceutical... |
MIPI |
10% Owner |
2011-01-28 |
2,361,377 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MIPI |
Molecular Insight Pharmac... |
10% Owner |
– – • |
2011-01-28 |
4 |
S |
$0.14 |
$9,570 |
D/D |
(59,000) |
2,361,377 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
10% Owner |
– – • |
2011-01-27 |
4 |
S |
$0.17 |
$6,510 |
D/D |
(38,000) |
2,420,377 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
10% Owner |
– – • |
2010-12-17 |
4 |
S |
$0.19 |
$30,710 |
D/D |
(155,000) |
2,458,377 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
10% Owner |
– – • |
2010-12-16 |
4 |
S |
$0.21 |
$9,680 |
D/D |
(45,000) |
2,613,377 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
10% Owner |
– – • |
2010-01-14 |
4 |
S |
$1.95 |
$11,566 |
D/D |
(5,800) |
2,658,377 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
10% Owner |
– – • |
2010-01-12 |
4 |
S |
$2.06 |
$8,313 |
D/D |
(4,000) |
2,664,177 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
10% Owner |
– – • |
2009-12-24 |
4/A |
S |
$2.34 |
$5,850 |
D/D |
(2,500) |
2,668,177 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Director |
– • • |
2009-12-24 |
4 |
S |
$2.34 |
$4,680 |
D/D |
(2,000) |
2,668,677 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
10% Owner |
– – • |
2009-12-23 |
4/A |
S |
$2.31 |
$28,319 |
D/D |
(12,000) |
2,670,677 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Director |
– • • |
2009-12-23 |
4 |
S |
$2.31 |
$31,909 |
D/D |
(13,500) |
2,668,177 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Director |
– • • |
2009-12-21 |
4 |
S |
$2.30 |
$14,718 |
D/D |
(6,300) |
2,683,677 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Director |
– • • |
2009-12-18 |
4 |
S |
$2.24 |
$12,400 |
D/D |
(5,500) |
2,689,977 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Director |
– • • |
2008-12-29 |
4 |
OE |
$1.20 |
$337,496 |
D/D |
81,249 |
2,695,477 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Chief Executive Officer |
• • • |
2008-05-20 |
4 |
A |
$0.01 |
$500 |
D/D |
50,000 |
2,614,228 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Chief Executive Officer |
• • • |
2007-11-30 |
4 |
B |
$8.35 |
$42,453 |
D/D |
5,000 |
2,564,227 |
3.23 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Chief Executive Officer |
• • • |
2007-11-20 |
4 |
B |
$6.62 |
$101,883 |
D/D |
15,000 |
2,559,228 |
3.23 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Chief Executive Officer |
• • • |
2007-11-08 |
4 |
OE |
$1.20 |
$210,004 |
D/D |
75,001 |
75,001 |
0 |
- |
|
| MIPI |
Molecular Insight Pharmac... |
Chief Executive OfficerOfficer |
• • • |
2007-02-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
866,780 |
|
- |
|
| MIPI |
Molecular Insight Pharmac... |
Chief Executive Officer |
• • • |
2007-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,602,447 |
1,602,447 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
